Wealth Enhancement Advisory Services LLC Purchases 79 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

Wealth Enhancement Advisory Services LLC grew its position in Inspire Medical Systems, Inc. (NYSE:INSP) by 1.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 7,879 shares of the company’s stock after buying an additional 79 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Inspire Medical Systems were worth $1,461,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. AQR Capital Management LLC raised its holdings in Inspire Medical Systems by 152.7% in the 2nd quarter. AQR Capital Management LLC now owns 231,845 shares of the company’s stock worth $31,028,000 after acquiring an additional 140,090 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of Inspire Medical Systems in the third quarter worth $1,929,000. Thrivent Financial for Lutherans lifted its holdings in shares of Inspire Medical Systems by 39.7% during the third quarter. Thrivent Financial for Lutherans now owns 110,580 shares of the company’s stock valued at $23,337,000 after purchasing an additional 31,444 shares in the last quarter. Scientech Research LLC purchased a new stake in shares of Inspire Medical Systems during the second quarter valued at $1,574,000. Finally, Allspring Global Investments Holdings LLC increased its holdings in Inspire Medical Systems by 798.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 267,852 shares of the company’s stock worth $56,530,000 after buying an additional 238,034 shares in the last quarter. Institutional investors own 94.91% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on INSP shares. Piper Sandler reaffirmed an “overweight” rating and set a $260.00 price target (up previously from $255.00) on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Royal Bank of Canada restated an “outperform” rating and issued a $260.00 target price on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Robert W. Baird boosted their target price on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the company an “outperform” rating in a research note on Tuesday, November 5th. Stifel Nicolaus restated a “hold” rating and issued a $200.00 price target (up from $170.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Finally, Bank of America upgraded Inspire Medical Systems from a “neutral” rating to a “buy” rating and upped their price objective for the company from $220.00 to $255.00 in a research report on Wednesday, November 20th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $233.58.

Inspire Medical Systems Stock Performance

NYSE:INSP opened at $176.27 on Thursday. The stock has a 50-day simple moving average of $190.78 and a two-hundred day simple moving average of $184.55. The firm has a market capitalization of $5.28 billion, a PE ratio of 164.74 and a beta of 1.32. Inspire Medical Systems, Inc. has a 52-week low of $123.00 and a 52-week high of $257.40.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The company had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. During the same period in the previous year, the company posted ($0.29) EPS. The firm’s revenue was up 32.6% on a year-over-year basis. Equities analysts forecast that Inspire Medical Systems, Inc. will post 1.33 earnings per share for the current fiscal year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.